Foghorn Therapeutics Inc. at H.C. Wainwright BioConnect Investor Conference Transcript
I'd like to welcome everybody back to the H.C. Wainwright BioConnect conference, and we are continuing with our afternoon session here. Our next presenter is Adrian Gottschalk, President and CEO of Foghorn Therapeutics. Welcome.
Great, Andres. Thanks. And you get extra points for pronouncing the last name correctly. So it's very rare that that ever happens. So just maybe credit that. Thanks for having me.
Questions & Answers
Of course. So I guess for investors who are not as familiar with the Foghorn story, could you give us a brief overview of the unique ways you're tackling various indications within oncology?
Sure. So maybe I'll just take a step back and talk about what we're actually working on and then talk about the drug immodality and our strategy to get after some of the unique targets on which we're focused.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
